Zepbound, ZEPBOUND, Zepbound KwikPen
- Manufacturer
- Eli Lilly
- ICD-10 indication
- E66.9
Affordability Check
How much will you actually pay for Zepbound, ZEPBOUND, Zepbound KwikPen?
In 30 seconds, see every legitimate way to afford Zepbound, ZEPBOUND, Zepbound KwikPen — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Zepbound, ZEPBOUND, Zepbound KwikPen
What is this medication? Zepbound is a prescription medication used for chronic weight management in adults who are living with obesity or who are overweight and have weight-related medical conditions such as high blood pressure, type 2 diabetes, or high cholesterol. It contains the active ingredient tirzepatide and is typically administered as a weekly subcutaneous injection using the Zepbound KwikPen. This medication is designed to be used in conjunction with a reduced-calorie diet and increased physical activity to help patients lose weight and maintain their weight loss over time.
The medication works by activating receptors for two natural hormones in the body known as glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. By mimicking these hormones, Zepbound helps to regulate appetite and signals the brain to feel full, while also slowing the rate at which food leaves the stomach. It is important for patients to follow the specific dosing schedule and instructions provided by their healthcare provider to achieve the best results and manage potential side effects.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Zepbound, ZEPBOUND, Zepbound KwikPen.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Zepbound, ZEPBOUND, Zepbound KwikPen →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Zepbound, ZEPBOUND, Zepbound KwikPen →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
ORLISTAT
Treats same condition · orlistat
Diethylpropion Hydrochloride ER
Treats same condition · Diethylpropion Hydrochloride
Diethylpropion Hydrochloride
Treats same condition · DIETHYLPROPION HYDROCHLORIDE
Isoniazid
Treats same condition · Isoniazid
Embriva
Treats same condition · ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE
Phentermine and topiramate
Treats same condition · phentermine and topiramate
Pregnyl
Treats same condition · CHORIOGONADOTROPIN ALFA
Phentermine
Treats same condition · PHENTERMINE HYDROCHLORIDE
Evekeo
Treats same condition · Amphetamine Sulfate
LISDEXAMFETAMINE DIMESYLATE
Treats same condition · Lisdexamfetamine
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.